P

Inventor

FAIRHURST ROBIN ALEC

GB43 patents
⚠️ This page may combine multiple inventors who share the name “FAIRHURST ROBIN ALEC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

20 patents
US6878721B1Apr 12, 2005

Beta2-adrenoceptor agonists

NOVARTIS AG29 citations96
US6800643B2Oct 5, 2004

Mixtures for organic compounds for the treatment of airway diseases

NOVARTIS AG59 citations95
US6087490AJul 11, 2000

Dinucleotide and oligonucleotide analogues

NOVARTIS AG16 citations82
US8865894B2Oct 21, 2014

Oxazolidin-2-one compounds and uses thereof

NOVARTIS AG10 citations81
US7989458B2Aug 2, 2011

Pyrimidine derivatives as alk-5 inhibitors

NOVARTIS AG12 citations81
US7008951B2Mar 7, 2006

Mixtures or organic compounds for the treatment of airway diseases

NOVARTIS AG5 citations73
US10130629B2Nov 20, 2018

Pharmaceutical combinations

NOVARTIS AG3 citations71
US7745462B2Jun 29, 2010

Quinoline-2-one derivatives for the treatment of airways diseases

NOVARTIS AG7 citations71
US6919337B2Jul 19, 2005

8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors

NOVARTIS AG9 citations69
US9040559B2May 26, 2015

BETA2-adrenoceptor agonists

NOVARTIS AG0 citations52
US10786492B2Sep 29, 2020

Formylated N-heterocyclic derivatives as FGFR4 inhibitors

NOVARTIS AG0 citations51
US11229643B2Jan 25, 2022

Combinations of FGFR4 inhibitors and bile acid sequestrants

NOVARTIS AG0 citations50
US10251868B2Apr 9, 2019

Benzothiazolone compound

NOVARTIS AG0 citations50
US9913828B2Mar 13, 2018

Benzothiazolone compound

NOVARTIS AG0 citations50
US7019136B2Mar 28, 2006

8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors

NOVARTIS AG0 citations50
US10507201B2Dec 17, 2019

Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors

NOVARTIS AG0 citations49
US10202371B2Feb 12, 2019

Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors

NOVARTIS AG0 citations47
US9623012B2Apr 18, 2017

Formulation comprising benzothiazolone compound

NOVARTIS AG1 citations47
US12226405B2Feb 18, 2025

Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use

NOVARTIS AG0 citations44
US8357707B2Jan 22, 2013

2-carboxamide cycloamino ureas

NOVARTIS AG0 citations41

FAIRHURST ROBIN ALEC

11 patents

BUSCHMANN NICOLE

5 patents

CUENOUD BERNARD

3 patents

CARAVATTI GIORGIO

2 patents

GUAGNANO VITO

1 patent

CAO JUN

1 patent